Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients

[1]  J. Madan,et al.  Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial , 2020, Bulletin of the World Health Organization.

[2]  Lin Zhou,et al.  Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China , 2020, BioMed research international.

[3]  Nandini Dendukuri,et al.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults , 2019, The Cochrane database of systematic reviews.

[4]  W. Muttamba,et al.  Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study , 2019, PloS one.

[5]  A. Bañuls,et al.  Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review , 2019, Front. Microbiol..

[6]  A. Van Deun,et al.  A Trial of a Shorter Regimen for Rifampin‐Resistant Tuberculosis , 2019, The New England journal of medicine.

[7]  A. Harries,et al.  High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011-2017. , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  G. Zandanga,et al.  Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017 , 2019, Open forum infectious diseases.

[9]  N. L. Oo,et al.  Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries. , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  M. Kaswa,et al.  Extensively resistant tuberculosis: Four cases in the Republic of Congo. , 2018, Medecine et sante tropicales.

[11]  B. Gicquel,et al.  Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon , 2017, Journal of Clinical Microbiology.

[12]  D. Cohen,et al.  Publisher's Note , 2017, Neuroscience & Biobehavioral Reviews.

[13]  H. Koornhof,et al.  Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa , 2016, Journal of Clinical Microbiology.

[14]  C. Gilpin,et al.  Current tools available for the diagnosis of drug-resistant tuberculosis , 2016, Therapeutic advances in infectious disease.

[15]  F.,et al.  Associated pulmonary tuberculosis in HIV patients in Department of Infectious Diseases of the University Hospital of Brazzaville: Prevalence and Associated factors , 2016 .

[16]  F. Brossier,et al.  Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains , 2016, Journal of Clinical Microbiology.

[17]  P. Kaleebu,et al.  Taking forward the World TB Day 2016 theme ‘Unite to End Tuberculosis’ for the WHO Africa Region , 2016, International Journal of Infectious Diseases.

[18]  R. S. Gupta,et al.  Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India , 2015, PloS one.

[19]  J. O’Grady,et al.  Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. , 2012, The Journal of infectious diseases.

[20]  Eduardo Gotuzzo,et al.  Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.

[21]  P. Escalante.  Tuberculosis , 1904, Annals of Internal Medicine.

[22]  E. Bemba,et al.  Apport du GeneXpert dans le diagnostic de la tuberculose pulmonaire : étude préliminaire et perspectives en République du Congo , 2015 .

[23]  F. Okemba-Okombi,et al.  Évaluation de la prise en charge des patients admis au régime de retraitement au Centre anti-tuberculeux de Brazzaville , 2015 .

[24]  E. Bemba,et al.  Analyse du rapport du Programme national de lutte contre la tuberculose (PNLT-Congo) sur la co-infection tuberculose/VIH , 2015 .